SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 646-657, abril 2022. ilus
Artigo
em Inglês
| IBECS
| ID: ibc-203769
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
The management of localized rectal cancer requires a multidisciplinary approach to optimize outcomes, reduce morbidity and prevent under or overtreatments. While early stages may obtain benefit of local resections without any additional therapies, locally advanced rectal cancer becomes a challenge defining the better sequential strategy of surgery, radiotherapy and chemotherapy. The latest results of international phase III studies have positioned the total neoadjuvant therapy as a potential new standard of care in high risk rectal cancers, however, the best schedule is still not well defined.
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Reto
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Terapia Neoadjuvante
/
Quimiorradioterapia
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Consorcio Hospital General Universitario de Valencia/Spain
/
Hospital Universitari Mútua de Terrassa/Spain
/
Hospital Universitario Clínico San Carlos/Spain
/
Hospital Universitario Reina Sofía/Spain
/
Hospital Universitario Son Espases/Spain
/
Hospital Universitario de Navarra/Spain
/
Hospital de la Santa Creu i Sant Pau/Spain
/
Hospital del Mar-IMIM/Spain
/
INCLIVA Biomedical Research Institute/Spain
/
Vall Hebron University Hospital/Spain